Neuropro Therapeutics, Inc.

This study is testing whether an experimental drug called NPT 2042 can reduce the frequency and duration of absence seizures in people with genetic generalized epilepsy. Ten participants aged 16-75 will try both the drug and a placebo in random order, with brain activity measured…

This early-stage study aims to see how a new version of an experimental capsule (NPT 2042) is absorbed by the body compared to the original version. It involves a small group of healthy adults who will take single doses of each capsule. The goal is to gather basic information to …